GVHD002: Safety Follow-Up Through 180 Days of Treatment with Remestemcel-L in Study MSB-GVHD001 in Pediatric Patients who have Failed to Respond to Steroid Treatment for acute GVHD.

Project: Research project

Project Details

StatusFinished
Effective start/end date10/19/1510/31/18

Funding

  • Mesoblast International Sarl (NA)